Hospital Ramos Mejía is a hospital in Buenos Aires, Argentina.

During the past decade, Hospital General de Agudos Dr. J. M. Ramos Mejia conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 21 clinical trials were completed, i.e. on average, 84% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 14 clinical trials were completed. i.e. 93.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital General de Agudos Dr. J. M. Ramos Mejia" #1 sponsor was "Kirby Institute" with 7 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "University of Minnesota" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Bristol-Myers Squibb" with 3 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General de Agudos Dr. J. M. Ramos Mejia" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 5 trials as a collaborator, "National Institutes of Health (NIH)" with 3 trials as a collaborator, "Abbott" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Hospital General de Agudos Dr. J. M. Ramos Mejia" are "Rheumatoid Arthritis" (5 trials), "HIV Infections" (3 trials), "Covid19" (2 trials), "HIV Infection" (2 trials) and "Hypertension" (2 trials). Many other conditions were trialed in "Hospital General de Agudos Dr. J. M. Ramos Mejia" in a lesser frequency.

Most popular intervention types in "Hospital General de Agudos Dr. J. M. Ramos Mejia" are "Drug" (39 trials), "Other" (6 trials), "Biological" (5 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Abatacept" (2 trials), "Darusentan" (2 trials), "Guselkumab" (2 trials) and "Guselkumab Dose 1" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital General de Agudos Dr. J. M. Ramos Mejia" are 47 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital General de Agudos Dr. J. M. Ramos Mejia". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Hospital General de Agudos Dr. J. M. Ramos Mejia, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital General de Agudos Dr. J. M. Ramos Mejia, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".